EQS-News: APONTIS PHARMA AG / Key word: Product Launch
APONTIS PHARMA: New development partnership with Midas Pharma – Expansion of Single Pill portfolio with EU-wide property. | April 12, 2023
EQS-News: APONTIS PHARMA AG / Key word(s): Product LaunchAPONTIS PHARMA: New development partnership with Midas Pharma – Expansion of Single Pill portfolio with EU-wide property rights opens up additional revenue potential 12.04.2023 / 07:30 CET/CESTThe issuer is solely responsible for the content of this announceme.
Gerresheimer’s first own IP autoinjector suitable for both small and large molecules enhances broad portfolio of solutions, medical devices, and pharmaceutical primary packaging.